Group One Trading, L.P. Glycomimetics Inc Transaction History

Group One Trading, L.P.

$2.54 Billion
Q4 2024

A detailed history of Group One Trading, L.P. transactions in Glycomimetics Inc stock. As of the latest transaction made, Group One Trading, L.P. holds 23,369 shares of GLYC stock, worth $6,543. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,369

Previous 38,017 38.53%

Holding current value

$6,543

Previous $6,000 16.67%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.14 - $0.54 $2,050 - $7,909	-14,648 Reduced 38.53%	23,369 $5,000
Q3 2024 Nov 14, 2024	SELL	$0.16 - $0.32 $4,386 - $8,773	-27,416 Reduced 41.9%	38,017 $6,000
Q2 2024 Aug 14, 2024	BUY	$0.24 - $3.04 $8,820 - $111,732	36,754 Added 128.16%	65,433 $18,000
Q1 2024 May 10, 2024	SELL	$2.55 - $3.49 $6,563 - $8,983	-2,574 Reduced 8.24%	28,679 $86,000
Q4 2023 Feb 14, 2024	BUY	$1.13 - $2.54 $3,222 - $7,244	2,852 Added 10.04%	31,253 $73,000
Q3 2023 Nov 09, 2023	SELL	$1.29 - $1.73 $33,202 - $44,526	-25,738 Reduced 47.54%	28,401 $42,000
Q2 2023 Aug 09, 2023	BUY	$1.21 - $2.08 $65,508 - $112,609	54,139 New	54,139 $94,000
Q4 2022 Feb 09, 2023	BUY	$0.57 - $3.03 $7,315 - $38,887	12,834 New	12,834 $38,000
Q2 2021 Aug 10, 2021	SELL	$2.16 - $3.18 $76,073 - $111,996	-35,219 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$2.89 - $4.22 $10,039 - $14,660	3,474 Added 10.94%	35,219 $106,000
Q4 2020 Feb 10, 2021	SELL	$2.69 - $4.24 $33,775 - $53,237	-12,556 Reduced 28.34%	31,745 $119,000
Q3 2020 Nov 12, 2020	BUY	$3.07 - $5.0 $136,004 - $221,505	44,301 New	44,301 $136,000
Q4 2019 Feb 10, 2020	SELL	$4.03 - $6.5 $5,025 - $8,105	-1,247 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$2.8 - $12.85 $691 - $3,173	247 Added 24.7%	1,247 $5,000
Q2 2019 Aug 09, 2019	BUY	$10.6 - $13.12 $10,600 - $13,120	1,000 New	1,000 $12,000
Q3 2018 Nov 08, 2018	SELL	$13.7 - $17.12 $23,331 - $29,155	-1,703 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$14.63 - $19.19 $4,389 - $5,757	300 Added 21.38%	1,703 $27,000
Q1 2018 May 11, 2018	SELL	$16.06 - $25.35 $88,859 - $140,261	-5,533 Reduced 79.77%	1,403 $23,000
Q4 2017 Feb 09, 2018	BUY	$10.51 - $17.22 $72,897 - $119,437	6,936	6,936 $116,000

Others Institutions Holding GLYC

# of Institutions

Shares Held

30.3M

Call Options Held

51K

Put Options Held

1.4K

View Full List

About GLYCOMIMETICS INC

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $14.7M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

More about GLYC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Glycomimetics Inc Transaction History